vs
Side-by-side financial comparison of Local Bounti Corporation (LOCL) and Relay Therapeutics, Inc. (RLAY). Click either name above to swap in a different company.
Local Bounti Corporation is the larger business by last-quarter revenue ($12.5M vs $7.0M, roughly 1.8× Relay Therapeutics, Inc.). Local Bounti Corporation produced more free cash flow last quarter ($-3.6M vs $-235.9M).
Local Bounti Corporation is a U.S.-based sustainable indoor agriculture firm growing fresh, pesticide-free leafy greens, herbs and produce via advanced hydroponic and vertical farming tech. It serves North American retail and food service partners, focusing on low environmental impact and stable year-round supply.
Relay Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies. It leverages advanced computational modeling of protein dynamics, paired with cutting-edge experimental biology, to design targeted medicines for previously intractable cancer types, serving global oncology care markets and patient populations.
LOCL vs RLAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.5M | $7.0M |
| Net Profit | $-8.7M | — |
| Gross Margin | 12.2% | — |
| Operating Margin | -106.1% | — |
| Net Margin | -69.8% | — |
| Revenue YoY | 23.7% | — |
| Net Profit YoY | 76.0% | — |
| EPS (diluted) | $1.52 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.5M | $7.0M | ||
| Q3 25 | $12.2M | $0 | ||
| Q2 25 | $12.1M | — | ||
| Q1 25 | $11.6M | $7.7M | ||
| Q4 24 | $10.1M | $0 | ||
| Q3 24 | $10.2M | $0 | ||
| Q2 24 | $9.4M | $0 | ||
| Q1 24 | $8.4M | $10.0M |
| Q4 25 | $-8.7M | — | ||
| Q3 25 | $-26.4M | $-74.1M | ||
| Q2 25 | $-21.6M | — | ||
| Q1 25 | $-37.7M | $-77.1M | ||
| Q4 24 | $-36.3M | — | ||
| Q3 24 | $-34.3M | $-88.1M | ||
| Q2 24 | $-25.3M | $-92.2M | ||
| Q1 24 | $-24.1M | $-81.4M |
| Q4 25 | 12.2% | — | ||
| Q3 25 | 11.5% | — | ||
| Q2 25 | 12.2% | — | ||
| Q1 25 | 12.6% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 13.8% | — | ||
| Q2 24 | 14.3% | — | ||
| Q1 24 | 9.4% | — |
| Q4 25 | -106.1% | — | ||
| Q3 25 | -149.4% | — | ||
| Q2 25 | -127.7% | — | ||
| Q1 25 | -135.6% | -1105.2% | ||
| Q4 24 | -166.6% | — | ||
| Q3 24 | -176.0% | — | ||
| Q2 24 | -146.8% | — | ||
| Q1 24 | -122.9% | -903.0% |
| Q4 25 | -69.8% | — | ||
| Q3 25 | -216.6% | — | ||
| Q2 25 | -178.3% | — | ||
| Q1 25 | -324.6% | -1003.6% | ||
| Q4 24 | -360.1% | — | ||
| Q3 24 | -335.2% | — | ||
| Q2 24 | -267.6% | — | ||
| Q1 24 | -286.9% | -813.3% |
| Q4 25 | $1.52 | — | ||
| Q3 25 | $-1.18 | $-0.43 | ||
| Q2 25 | $-1.63 | — | ||
| Q1 25 | $-4.32 | $-0.46 | ||
| Q4 24 | $-4.24 | — | ||
| Q3 24 | $-4.01 | $-0.63 | ||
| Q2 24 | $-3.00 | $-0.69 | ||
| Q1 24 | $-2.89 | $-0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.2M | $84.0M |
| Total DebtLower is stronger | $483.1M | — |
| Stockholders' EquityBook value | $-166.2M | $567.1M |
| Total Assets | $410.5M | $621.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.2M | $84.0M | ||
| Q3 25 | $6.2M | $91.6M | ||
| Q2 25 | $5.3M | — | ||
| Q1 25 | $18.0M | $93.5M | ||
| Q4 24 | $937.0K | $124.3M | ||
| Q3 24 | $317.0K | $152.4M | ||
| Q2 24 | $9.7M | $134.1M | ||
| Q1 24 | $8.2M | $152.9M |
| Q4 25 | $483.1M | — | ||
| Q3 25 | $484.9M | — | ||
| Q2 25 | $478.3M | — | ||
| Q1 25 | $480.0M | — | ||
| Q4 24 | $436.8M | — | ||
| Q3 24 | $398.4M | — | ||
| Q2 24 | $374.0M | — | ||
| Q1 24 | $329.8M | — |
| Q4 25 | $-166.2M | $567.1M | ||
| Q3 25 | $-158.1M | $607.7M | ||
| Q2 25 | $-132.7M | — | ||
| Q1 25 | $-134.5M | $721.1M | ||
| Q4 24 | $-100.5M | $777.8M | ||
| Q3 24 | $-65.6M | $838.9M | ||
| Q2 24 | $-32.8M | $681.7M | ||
| Q1 24 | $-9.4M | $745.8M |
| Q4 25 | $410.5M | $621.3M | ||
| Q3 25 | $417.8M | $670.0M | ||
| Q2 25 | $426.8M | — | ||
| Q1 25 | $447.2M | $799.4M | ||
| Q4 24 | $428.0M | $871.3M | ||
| Q3 24 | $430.8M | $930.1M | ||
| Q2 24 | $438.1M | $772.5M | ||
| Q1 24 | $413.4M | $841.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.1M | $-235.5M |
| Free Cash FlowOCF − Capex | $-3.6M | $-235.9M |
| FCF MarginFCF / Revenue | -29.1% | -3370.0% |
| Capex IntensityCapex / Revenue | 3.9% | 5.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-42.9M | $-622.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.1M | $-235.5M | ||
| Q3 25 | $-8.9M | $-62.1M | ||
| Q2 25 | $-8.7M | — | ||
| Q1 25 | $-9.6M | $-73.2M | ||
| Q4 24 | $1.2M | $-249.1M | ||
| Q3 24 | $-17.2M | $-75.1M | ||
| Q2 24 | $-4.0M | $-65.8M | ||
| Q1 24 | $-7.1M | $-50.3M |
| Q4 25 | $-3.6M | $-235.9M | ||
| Q3 25 | $-10.1M | $-62.1M | ||
| Q2 25 | $-14.6M | — | ||
| Q1 25 | $-14.5M | $-73.6M | ||
| Q4 24 | $-8.6M | $-251.1M | ||
| Q3 24 | $-30.0M | $-75.3M | ||
| Q2 24 | $-28.8M | $-65.8M | ||
| Q1 24 | $-42.1M | $-52.1M |
| Q4 25 | -29.1% | -3370.0% | ||
| Q3 25 | -82.8% | — | ||
| Q2 25 | -121.0% | — | ||
| Q1 25 | -125.1% | -958.4% | ||
| Q4 24 | -85.3% | — | ||
| Q3 24 | -293.1% | — | ||
| Q2 24 | -305.4% | — | ||
| Q1 24 | -501.8% | -520.7% |
| Q4 25 | 3.9% | 5.9% | ||
| Q3 25 | 9.7% | — | ||
| Q2 25 | 48.9% | — | ||
| Q1 25 | 42.8% | 5.0% | ||
| Q4 24 | 97.6% | — | ||
| Q3 24 | 125.0% | — | ||
| Q2 24 | 263.0% | — | ||
| Q1 24 | 417.3% | 17.8% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
